Plasma Aβ42 as Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study
出版年份 2018 全文链接
标题
Plasma Aβ42 as Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study
作者
关键词
-
出版物
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-12
出版商
IOS Press
发表日期
2018-08-22
DOI
10.3233/jad-180321
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers
- (2018) Olivier Hanon et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Amyloid blood biomarker detects Alzheimer's disease
- (2018) Andreas Nabers et al. EMBO Molecular Medicine
- From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer’s Disease
- (2018) Henrik Zetterberg et al. JOURNAL OF ALZHEIMERS DISEASE
- A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
- (2018) Liu Shi et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease
- (2018) Charlotte E. Teunissen et al. JOURNAL OF ALZHEIMERS DISEASE
- Gender-related increase of tropomyosin-1 abundance in platelets of Alzheimer's disease and mild cognitive impairment patients
- (2018) Christina Maria Reumiller et al. Journal of Proteomics
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Associations of plasma clusterin and Alzheimer’s disease-related MRI markers in adults at mid-life: The CARDIA Brain MRI sub-study
- (2018) Thaddeus Haight et al. PLoS One
- Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
- (2018) Vijay R. Varma et al. PLOS MEDICINE
- Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays
- (2018) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer’s disease
- (2017) Subodh Kumar et al. HUMAN MOLECULAR GENETICS
- Multivariate analyses of peripheral blood leukocyte transcripts distinguish Alzheimer's, Parkinson's, control, and those at risk for developing Alzheimer's
- (2017) Elaine Delvaux et al. NEUROBIOLOGY OF AGING
- Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)
- (2017) Pradeep J. Nathan et al. NEUROBIOLOGY OF AGING
- Mitochondrial genes are altered in blood early in Alzheimer's disease
- (2017) Katie Lunnon et al. NEUROBIOLOGY OF AGING
- Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
- (2017) Min Jeong Wang et al. Alzheimers Research & Therapy
- A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
- (2017) Steve Pedrini et al. Scientific Reports
- Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology
- (2016) Lei Yu et al. Alzheimers & Dementia
- Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’
- (2016) S. Galluzzi et al. JOURNAL OF INTERNAL MEDICINE
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Genetic Loci Associated with Alzheimer’s Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort
- (2013) Lyzel S. Elias-Sonnenschein et al. PLoS One
- Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
- (2013) Jon B Toledo et al. Alzheimers Research & Therapy
- The Role of Clusterin in Amyloid-β–Associated Neurodegeneration
- (2013) Rahul S. Desikan et al. JAMA Neurology
- Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
- (2012) Michal J. Figurski et al. Alzheimers & Dementia
- Plasma Clusterin and the Risk of Alzheimer Disease
- (2011) Elisabeth M. C. Schrijvers JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
- (2010) Madhav Thambisetty et al. ARCHIVES OF GENERAL PSYCHIATRY
- Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease
- (2010) Minerva M. Carrasquillo et al. ARCHIVES OF NEUROLOGY
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
- (2007) Miroslaw Brys et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started